X4W-84131-81831
2 vaccinations
1 coded response
18 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 837 / ID
- Registered
- 2021-08-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-13
Registered in v-safe
-
2021-08-13
Dose 1 — Pfizer-BioNTech
- 2021-08-13
-
2021-08-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-08-15
- 2021-08-16
- 2021-08-18
- 2021-08-27
-
2021-09-12
Dose 2 — Pfizer-BioNTech
- 2021-09-12
-
2021-09-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-14
- 2021-09-15
- 2021-09-16
- 2021-09-18
- 2021-09-21
-
2021-09-26
Survey response — day 14, dose 2MedDRA: Dyspnoea, Oropharyngeal pain, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat. Shortness of breath. Congestion.MedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-10
- 2021-10-17
- 2021-10-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-13 | Pfizer-BioNTech | No |
| 2 | 2021-09-12 | Pfizer-BioNTech | No |
Free text
Release 9 — day 14, dose 2
Symptoms: Sore throat. Shortness of breath. Congestion.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release